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Algae have been recognized as important resources providing functional components
due to their capacity to exert beneficial effects on health. Therefore, there is increasing
interest in investigating the biological activity of algae. In this study, we evaluated
the antidepressant-like effect of the administration of 100 mg/kg/day of the ethanol
extract of colonial green alga Botryococcus braunii (EEB) for 14 consecutive days in
the forced swimming test (FST)-induced depression in imprinting control region (ICR)
mice. Imipramine, a commercial antidepressant drug, was used as a positive control.
In addition, we investigated the molecular mechanisms underlying the effect of EEB
by measuring ATP production and by assessing any change in gene expression at the
end of the treatment using real-time polymerase chain reaction (PCR) and microarray
assays. We showed that the immobility time in the water-administered control (FST
stress) group gradually increased from day 1 to day 14. However, treatment with EEB
caused a significant decrease of immobility time in the FST compared with that in the
FST stress group. Microarray and real-time PCR results revealed that EEB treatment
induced variation in the expression of several genes associated with neurogenesis,
energy metabolism, and dopamine synthesis. Interestingly, we revealed that only EEB
treatment enhanced the promotion of energy production, while treatment with imipramine
was ineffective. Our study provides the first evidence that B. braunii enhances energy
production, which may contribute to the modulation of neurogenesis and to the
enhancement of dopaminergic function, in turn potentially underlying the antistress- and
antidepressant-like effects that we observed.
Keywords: microalgae, Botryococcus braunii, depression, forced swimming test, dopamine synthesis, energy
promotion activity, neurogenesis
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INTRODUCTION
Stress is a part of everyday life and particularly prevalent in
modern societies. There are various sources of stress in people’s
lives, and excessive or prolonged exposure to such stress factors
has a significant impact on our wellbeing, ultimately leading
to emotional and behavioral changes, together with reduced
cognitive function and physical illness. Therefore, it is not
surprising that stress remains a top health concern, particularly
in developed countries. The damaging effect of stress on cells
is well-documented; in particular, stress affects neuronal cells
and may lead to the induction of neurodegenerative disorders,
such as Alzheimer’s disease, Parkinson’s disease, and major
depression. Depression is a psychiatric disorder commonly
characterized by a sense of prostration; in its most severe
forms, it can be life-threatening. This disorder has a worldwide
prevalence of ∼17% (Liu et al., 2013). Depression, which is
the most common type of affective disorders, is caused by
a combination of biological, psychological, social, and other
factors. Depressive syndrome is characterized by significant and
lasting lowmood (Lu et al., 2015). In clinical practice, drug classes
used for the treatment of depression include monoamine oxidase
inhibitors, selective serotonin noradrenaline reuptake inhibitors
(SNRIs), selective serotonin reuptake inhibitors, and tricyclic
antidepressants (Bouvier et al., 2003; Fava, 2003; Shen and Liang,
2007). However, these drugs can cause a variety of adverse effects,
including nausea, headaches, and nerve pain. Therefore, new and
safer antidepressants, which are derived from natural products
and lack side effects, need to be developed.
Algae are photosynthetic organisms that mainly inhabit the
hydrosphere. They form a large and diverse group within which
over 40,000 species have been described so far. However, the
total number of algal species is estimated to exceed 10 million,
including those that remain undiscovered and undescribed
(Norton et al., 1996). Some algae and particularly microalgae
have served as important sources of functional materials, such
as n-3 polyunsaturated fatty acids (PUFA), vitamins, minerals,
polysaccharides, and bioactive compounds (Shahidi and Janak
Kamil, 2001). Moreover, microalgae are known to exhibit various
biological and physiological activities, including antioxidant,
anticoagulant, antiviral, and antitumoral effects (Pangestuti and
Kim, 2011). Therefore, we speculated that microalgae have the
potential to be a valuable natural resource of novel bioactive
compounds and focused on the colonial green alga Botryococcus
braunii Kützing (Trebouxiophyceae, Chlorophyta), which is
found worldwide in freshwater and brackish lakes, reservoirs,
and ponds. B. braunii produces large amounts of hydrocarbons,
which are excreted from cells and accumulate in its colonies.
Therefore, it is considered to have great potential as a renewable
source of chemical products and is useful for searching for new
antidepressant drugs.Moreover, to the best of our knowledge, few
reports on studies exploring the physiological effects of B. braunii
have been published.
The objectives of this study were to evaluate the
antidepressant-like effect of ethanol extract of B. braunii
(EEB), using the forced swimming test (FST) to obtain a rodent
model of depression by inducing stress in imprinting control
region (ICR) mice, and to understand the molecular mechanism
behind the antidepressant-like effect of EEB. We also focused
our attention on changes in expression levels for genes associated
with neurogenesis, energy promotion activity, and dopamine
synthesis. In addition, we analyzed the neuroprotective effect of
EEB using rat pheochromocytoma PC12 cells.
MATERIALS AND METHODS
Preparation of Ethanol Extract of B. braunii
(EEB)
A dried sample of B. braunii was provided by ABES, the
University of Tsukuba, Japan. The dried sample was extracted
using 99.5% ethanol, in the dark, and at room temperature for
2 weeks, with shaking of the mixture occurring at least once
a day. At the end of the procedure, the liquid fraction (EEB)
was collected, filtered through a 0.22-µm filter (Merck Millipore,
Billerica, MA, USA), and used in the in vitro assays. For animal
dosing in the in vivo assay, EEB was concentrated using SpeedVac
(Thermo Fisher Scientific, Waltham, MA, USA) and the dried
EEB was dissolved in MilliQ water.
Animals
Male ICR mice (Charles River Laboratories Japan Inc.,
Yokohama, Kanagawa, Japan), 5 weeks old, weighing 35–
40 g, were used for in vivo experiments. The animals were kept
individually in cages and maintained with free access to water
and food ad libitum, under a 12/12-h light/dark cycle. All of
the experiments were carried out between 09:00 and 16:00, and
the animals had been acclimatized for 7 days to the laboratory
conditions ahead of the experiment. This animal experiment was
approved by the Ethics Animal Care and Use Committee of the
University of Tsukuba.
Administration of Ethanol Extract of
B. braunii (EEB) to ICR Mice
After 1 week of acclimatization to the laboratory conditions, mice
were assigned to three groups: a control group (n = 8), a group
administered 20 mg/kg imipramine daily (n = 8), and a group
administered 100 mg/kg EEB daily (n = 8). EEB dissolved in
drinking water was administered orally using a tube and a syringe
for 14 consecutive days. The control group was administered an
equivalent volume of tap water.
Imipramine, an SNRI antidepressant drug that selectively
increases dopamine and noradrenaline levels in the synaptic cleft,
was used as a positive control. Imipramine was freshly dissolved
in distilled water and orally administered to mice at a dose of
20 mg/kg, as reported in our previous study (Ben Othman et al.,
2013).
Forced Swimming Test
The FST was conducted as previously described by Ben Othman
et al. (2013) To carry out the FST, we used a cylindrical jar (14
cm in diameter × 25 cm in height) filled from the bottom with
19 cm of water at 25 ± 1◦C. The FST was performed at 1, 2,
6, 10, and 14 d during the period of the oral administration of
EEB. Each mouse was placed gently into the water and allowed
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to swim freely for 5min. The mouse was considered immobile
when it showed disparity and became motionless in the water.
Periods of immobility were defined as when mice only made
those movements that were necessary to keep their head above
the water. The duration of immobility was recorded and analyzed
off-line over the last 4min of the test.
RNA Isolation from Mouse Brain
Following the last FST at day 14, all mice were sacrificed by
dislocation of the cervical spine and their brains were isolated.
A small amount (0.1mg) of cerebral tissue was removed and
washed with ice-cold phosphate-buffered solution (PBS). The
total RNA was extracted from it using the ISOGEN kit (Nippon
Gene Co. Ltd., Toyama, Japan), as we reported previously (Sasaki
et al., 2013). Total RNAwas quantified and assessed for its quality
with the NanoDrop 2000 spectrophotometer (Thermo Scientific,
Wilmington, DE, USA).
DNA Microarray Analysis
DNA microarray analysis was conducted on isolated RNA
samples from brains treated with EEB. DNA microarray analysis
was performed as reported previously (Isoda et al., 2012; Samet
et al., 2015). Double-stranded cDNA was synthesized from
100 ng of total RNA with the GeneAtlas 3′ IVT Express Kit
(Affymetrix Inc., Santa Clara, CA, USA). Biotin-labeled amplified
RNA (aRNA) was synthesized by in vitro transcription using the
GeneChip 3′ IVT Express Kit (Affymetrix Inc., Santa Clara, CA,
USA). A total of 9.4mg of purified aRNA was fragmented using
the GeneAtlas 3′ IVT Express Kit and was hybridized for 16 h
at 45◦C using GeneChip MG-430 PM microarray (Affymetrix
Inc., Santa Clara, CA, USA). The chip was washed and stained
in the Gene Atlas Fluidics Station 400 (Affymetrix Inc., Santa
Clara, CA, USA) and then the resulting image was scanned
using the GeneAtlas Imaging Station (Affymetrix Inc., Santa
Clara, CA, USA). Data analysis was performed using the Partek
Express software (Partek Inc., St. Louis, MO, USA) provided by
Affymetrix as part of their GeneAtlas system. Compared with the
control (water-treated group), fold change in expression in the
imipramine- or EEB-treated group was calculated and converted
to log 2 data.
Taqman Quantitative RT-PCR Analysis of
Gene Expression in Mouse Brain
Based on the microarray analysis, reverse transcription reactions
were carried out with the SuperScript III Reverse Transcriptase
(RT) kit (Invitrogen, Carlsbad, CA, USA). In accordance with
the manufacturer’s instructions, 1 µg of total RNA and 1
µl of oligo(dT)12–18 primers were denatured at 65
◦C for
5min and subsequently chilled at 4◦C. After the addition of
SuperScript III RT (200U), the reaction mix was incubated
at 42◦C for 60min, followed by another 10min at 70◦C.
All primer sets and TaqMan probes for experimental genes
were from Applied Biosystems (Foster City, CA, USA): mouse
tyrosine hydroxylase (TH) (Mm00447557_m1), mouse pyruvate
carboxylase (PC) (Mm00500992_m1), mouse brain-derived
neurotrophic factor (BDNF) (Mm04230607_s1), and mouse
GAPDH (Mm99999915_g1). For the quantification of mRNA,
TaqMan Real Time-PCR amplification reactions were carried
out using an AB 7500 Fast Real-Time PCR system (Applied
Biosystems). Amplifications were performed in a final volume of
20 µl, using 10 µl of TaqMan Universal PCR Master Mix UNG
(Applied Biosystems), 1 µl of the corresponding primer/probe
mix, and 9 µl of template cDNA (final concentration 100 ng/20
µl). Cycling conditions were as follows: 2min at 50◦C, 10min at
95◦C, and 40 cycles at 95◦C for 15 s followed by 60◦C for 1min.
Measurement of Brain ATP Content
ATP levels in the bupropion tissues were measured with
firefly bioluminescence using a luminescence luciferase assay kit
(TOYO Ink, Tokyo, Japan). A small amount (0.1mg) of cerebral
tissue was homogenized with 10mL of ice-cold homogenate
buffer (0.25M sucrose, 10mM HEPES-NaOH, pH 7.4). After
centrifugation, the supernatant was collected and 100µL of it was
transferred to a 96-well plate. After adding 100 µL of luciferin-
luciferase solution (TOYO Ink, Tokyo, Japan), 150 µL of the
mixed solution was transferred to another 96-well plate and
incubated for 10min. After 10min of incubation, light emission
was recorded using a luminometer (Powerscan HT; Dainippon
Pharmaceutical, Osaka, Japan).
Cell Culture
PC12 cell culture and MTT assay were performed in accordance
with our previous work (Sasaki et al., 2013). PC12 cells
(RIKEN, Tsukuba, Japan) were cultured in 75 cm2 flasks (BD
Biosciences, San Jose, CA, USA) and maintained in Dulbecco’s
Modified Eagle’s Medium (DMEM) (Sigma-Aldrich, St. Louis,
MO, USA) containing 10% heat-inactivated horse serum (Gibco,
Yokohama, Japan), 5% fetal bovine serum (Sigma-Aldrich), and
supplemented with 100 U·ml−1 penicillin and 100 µg·ml−1
streptomycin (ICN Biomedicals, Tokyo, Japan), in a water-
saturated 5% CO2 atmosphere at 37
◦C. For the experiments in
this study, cells were used between passage 3 and passage 8.
MTT Assay for Neuroprotection
Cell viability was measured using the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay. PC12 cells (1
× 105 cells·ml−1) cultured in a 96-well plate (BD Biosciences)
were pretreated with 1/1,000 dilution of EEB for 10min, followed
by the addition of 200µM corticosterone (Sigma-Aldrich, St.
Louis, MO, USA) for 48 h. After sample treatment, 100 µl of
culture medium and 10 µl of MTT (5 mg·ml−1) were added
and the cells were incubated for 6 h. The MTT formazan formed
was dissolved in 100 µl of 10% SDS (w/v) and the absorbance
was measured using a microtiter plate reader (Powerscan HT;
Dainippon Sumitomo Pharma Co. Ltd., Osaka, Japan).
Statistical Analysis
Results are expressed as mean ± standard error of the mean
(SEM). Statistical analysis of the results obtained in the FST
was carried out using two-way ANOVA with Ryan-einot-gabriel-
welsch multiple range test. One-way ANOVA followed by Ryan-
einot-gabriel-welsch multiple range test was also used. The
statistical evaluation was performed using the Student’s t-test
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between control and corticosterone-treatment group in in vitro
experiment. A P < 0.05 was considered statistically significant.
RESULTS
EEB Reversal of Depression-Like Behavior
Induced by FST
FST is a behavioral animal model that has been widely adopted
for investigating depression. To determine whether EEB has
antidepressant-like activity, its effect on FST-induced stress in
mice was investigated. The administration of 100 mg/kg EEB
for 14 consecutive days caused no mortality or significant
body weight change in any animal. As shown in Figure 1, the
immobility time in the water-administered control (FST stress)
group gradually increased from day 1 to day 14 (D = day; D1,
46.5 ± 13.2 s; D2, 55.4 ± 12.0 s; D6, 68.4 ± 11.5 s; D10, 71.5 ±
7.14 s; D14, 80.3± 6.40 s; P < 0.05). However, this trend was not
observed in the imipramine- and EEB-administered groups.
At day 14, the average immobility time for the
EEB-administered group (33.3 ± 7.0 s) was similar to that
in the imipramine-administered group (26.3 ± 10.7 s), which
represented our positive control (Figure 1). In mice treated with
imipramine, EEB induced a three-fold reduction of the average
immobility time compared with that in the water-administered
control mice (80.3± 6.40 s; P < 0.01).
EEB-Induced Variation of Energy
Metabolism-, Dopamine Production-, and
Neurogenesis-Related Gene Expression
To evaluate the molecular mechanism behind the
antidepressant-like effect of EEB, we performed microarray
FIGURE 1 | Effects of administration of ethanol extract of Botryococcus
braunii (EEB) on the immobility time in the forced swimming test (FST). Mice
were orally administered water (control), imipramine (20 mg/kg), and EEB (100
mg/kg) daily for 14 consecutive days. FST was carried out on days 1, 2, 6, 10,
and 14. The immobility time during the final 4min of a 5-min total session was
measured. FST immobility time measured for each group. Each data point
expressed as the means ± SEM (n = 8) and were analyzed by two-way
ANOVA followed by Ryan-einot-gabriel-welsch multiple range test, **P < 0.01
vs. control group.
analysis of ICR mouse cerebrum to investigate changes in
gene expression. We found that the expression of eight genes
was altered in the ICR mice administered EEB compared with
their levels in the control group (Table 1). These included the
short stature homeobox 2 (Shox2), paired-like homeodomain
transcription factor 2 (Pitx2), teashirt zinc finger family member
1 (Tshz1), and LIM homeobox protein 9 (Lhx9) genes associated
with neurogenesis (P < 0.05; compared with the control
group). Moreover, the expression of the polyribonucleotide
nucleotidyltransferase 1 (Pnpt1) gene associated with energy
metabolism was upregulated, while that of the arrestin domain
containing 4 (Arrdc4) gene involved in the regulation of
ATP production was downregulated (P < 0.05; compared
with the control group). In addition, the expression of two
genes associated with dopamine synthesis was modulated: the
arginine/serine-rich coiled-coil 1 (Rsrc1) gene was upregulated,
while the protein phosphatase 1, regulatory (inhibitor) subunit
1B (Ppp1r1b) gene was downregulated (P < 0.05; compared
with the control group). A similar pattern of alterations of
expression for the genes involved in neurogenesis and dopamine
synthesis was observed in the imipramine-administered group.
In summary, our results show that the administration of EEB
induced variation in the expression of energy metabolism-,
dopamine production-, and neurogenesis-related genes.
EEB-Induced Upregulation of BDNF, TH,
and PC Gene Expression in ICR Mouse
Cerebrum
Based on the results obtained from the microarray analysis, we
investigated the mRNA expression levels of TH, PC, and BDNF
in the ICR mouse cerebrum from the four experimental groups.
Real-time (RT) PCR results (Figure 2) showed that the mRNA
expression levels of TH were significantly upregulated in the
EEB-administered groups (168.6 ± 21.0%, compared with the
control group; P < 0.01; Figure 2A). The mRNA expression
levels of PC and BDNF were also upregulated in the EEB-
administered groups (PC: 142 ± 14.6% compared with the
control group, P < 0.01; BDNF: 151.1 ± 22.4% compared with
the control group, P < 0.01; Figures 2B,C). The administration
of imipramine induced the overexpression of TH and BDNF,
while it did not affect the mRNA level of PC (Figure 2).
EEB-Induced Production of ATP in ICR
Mouse Cerebrum
The results obtained from the microarray analysis and RT-
PCR showed that the upregulation of PC expression occurred
in the EEB-administered groups, but not in the imipramine-
administered mice. This indicates that EEB may increase the
energy level of mice. Therefore, we determined the ATP
content in the brains of the mice administered EEB. ATP is a
multifunctional nucleotide referred to as the “molecular unit of
currency” of intracellular energy transfer. It is also widely used as
a marker of cell proliferation as it transports the chemical energy
necessary for metabolic activity into the cells. The levels of ATP
production in the EEB-administered mice were measured using
a luciferase method. Mice administered EEB had significantly
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TABLE 1 | Classification of the modulated genes and their fold change in expression in imipramine- and EEB-administered imprinting control region mice in comparison
to the control, as identified by DNA microarray analysis.
Gene
symbol
Gene name Fold change (Control
vs. imipramine)
Fold change
(Control vs. EEB)
Molecular function Associated
phenotype
Shox2 Short stature homeobox 2 2.41** 3.09** Plays an important role during the cerebellar
neurogenesis, by maintaining the bone
morphogenetic protein expression levels (Rosin
et al., 2015)
Neurogenesis
Pitx2 Paired-like homeodomain
transcription factor 2
1.84* 2.37* Necessary for the normal development of the
subthalamic nucleus
Tshz1 Teashirt zinc finger family
member 1
2.24** 2.02** Maintain the expression of the prokineticin
receptor 2, a G protein–coupled receptor
essential for OB development and related to
prokineticin signaling (Ragancokova et al.,
2014)
Lhx9 LIM homeobox protein 9 1.69** 1.39* The typical marker genes of neurogenesis at
the stage of immature neuronal cells (Ng et al.,
2005).
Pnpt1 Polyribonucleotide
nucleotidyltransferase 1
1.06 2.05** Gene encoding for PNPase, associate with
Mitochondrial importation of nucleus-encoded
RNAs (Kamenski et al., 2007; Tarassov et al.,
2007; Duchene et al., 2009; Smirnov et al.,
2011).
Energy
Promotion
Arrdc4 Arrestin domain containing 4 −1.08 −1.33** Negative regulator of glucose uptake (Patwari
et al., 2009)
Rsrc1 Arginine/serine-rich
coiled-coil 1
1.63** 1.49** Function in dopamine, glutamate, and
fibroblast growth factor receptor signaling
(Potkin et al., 2009)
Dopamine
synthesis
Ppp1r1b Protein phosphatase 1,
regulatory (inhibitor) subunit
1B
−3.83** −5.54** Involved in the regulation of dopaminergic and
glutaminergic signaling (Albert et al., 2002;
Svenningsson et al., 2002)
Table values are expressed as mean ± SEM for three mice in each group. *P < 0.05, **P < 0.01 in comparison to control mice.
upregulated levels of luminescence (152.8 ± 25.9%) compared
with the control group (P < 0.05; Figure 3). In contrast, ATP
levels of imipramine-administered mice were not significantly
altered (Figure 3).
EEB-Mediated Protection against
Corticosterone-Induced Cell Death
We next performed the MTT assay to investigate the viability
of PC12 cells after treatment with corticosterone. Application
of 200µM corticosterone significantly decreased cell viability
to 42.4 ± 4.3% compared with that of untreated cells (P <
0.01; Figure 4). However, pretreatment with a 1/1,000 dilution of
EEB for 10min reversed this corticosterone-induced cell death,
resulting in a significant increase of cell viability by 34.3 ± 3.2%
compared with that in the corticosterone-treated group” and
revise (P < 0.01; Figure 4).
DISCUSSION
The present study was conducted to investigate the potential
antidepressant-like effect of the microalga B. braunii and to
elucidate the mechanism behind this effect. It is estimated that
about 72,500 algal species have been characterized globally
(Guiry, 2012). Algae produce bioactive secondary metabolites
that include polyphenolic compounds, polysaccharides,
steroids, fatty acids, carotenoids, mycosporine-like amino
acids, halogenated compounds, polyketides, lectins, peptides,
and their derivatives (Faulkner, 2001; Cardozo et al., 2007).
Among the large number of biological functionalities of
marine algal natural products, antioxidant, anti-inflammatory,
anticancer, immunomodulatory, antidiabetic, antimicrobial,
anticoagulant, tyrosinase inhibitory, and UV-protective effects
have been highlighted, based on extensive studies (Blunt
et al., 2015). However, there have been no reports on the
antidepressant-like effect of B. braunii. Therefore, the discovery
of novel antidepressants from these microalgae could provide
new insight in the fields of biomedical and pharmaceutical
research.
The FST is a standard animal model for behavioral
measurement of depression. In this test, the degree to which
the animal ceases to struggle and becomes relatively passively
immobile is used to assess the depressive behavior. Immobility
displayed in this behavioral model has been hypothesized to
reflect behavioral despair, which may mimic depressive disorders
in humans. Moreover, there is a significant correlation between
the clinical potency of antidepressants and the potency of the
same drugs in this model. Therefore, FST is usually adopted to
screen or evaluate antidepressant drugs (Porsolt et al., 1978).
The current study showed that the duration of immobility in
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FIGURE 2 | Effect of the administration of ethanol extract of Botryococcus
braunii (EEB) on mRNA expression of pyruvate carboxylase (PC), brain-derived
neurotrophic factor (BDNF), and tyrosine hydroxylase (TH) in imprinting control
region mouse cerebrum. Mice were orally administered water (control),
imipramine (20 mg/kg), and EEB (100 mg/kg) daily for 14 consecutive days.
Gene expression levels of TH (A), PC (B), and BDNF (C) were normalized to
the GAPDH level and were expressed as the ratio of that in the control group.
Values are expressed as the means ± SEM (n = 3 independent experiments)
and were analyzed by one-way ANOVA followed by
Ry8an-einot-gabriel-welsch multiple range test, **P < 0.01 vs. control group.
the FST was significantly decreased after the administration of
100 mg/kg EEB, indicating that B. braunii has antidepressant
effects. Furthermore, the oral administration of B. braunii
showed a comparable effect to that of imipramine, a commercial
antidepressant drug.
Microarray studies have been utilized as a useful tool to
characterize depression-related biomarkers in patients as well
as to further our understanding of the mechanisms underlying
depression in rodent models of this disease. In this study, we
identified eight genes that may be related to the pathophysiology
of depressive-like behavior induced by FST-related stress.
Three biological pathways (I: dopamine synthesis; II: energy
metabolism; III: neurogenesis) were identified to be significantly
altered in EEB-administered groups compared with their levels
in the control group.
As proposed by Li et al. (2015), the monoamine hypothesis
suggests that major depression might result from the
dysregulation of monoaminergic neurotransmitters such
as dopamine, serotonin, and norepinephrine in the central
nervous system. Dopamine is the most abundant monoamine
neurotransmitter in the brain, and plays a critical role in the
regulation of emotions, motivation, cognition, reward circuits,
and reinforcement behavior (Nieoullon and Coquerel, 2003;
Wise, 2004; Perkins et al., 2008). In this study, microarray results
showed that EEB induced downregulation of the Ppp1r1b gene,
which encodes the dopamine- and cAMP-regulated neuronal
phosphoprotein (DARPP-32). DARPP-32 is involved in the
regulation of dopaminergic and glutaminergic signaling, and
it has been implicated in various neurological and psychiatric
disorders including schizophrenia (Albert et al., 2002) and
depression (Svenningsson et al., 2002). In addition, EEB also
induced overexpression of the Rsc1 gene, which functions in
dopamine, glutamate, and fibroblast growth factor receptor
signaling (Potkin et al., 2009). Moreover, we determined
the mRNA expression of tyrosine hydroxylase (or tyrosine
3-monooxygenase, TH), the rate-limiting enzyme in the
biosynthesis of the catecholamine neurotransmitters dopamine
(DA) and norepinephrine (NE), and of adrenaline in neurons.
The regulated activity of TH is thought to play a critical role in
modulating the functional activity of the dopaminergic neuronal
systems in the brain (Fu et al., 2006). Catecholamines, such as
DA and NE, are known to play an important role in several
behavioral and neurodegenerative diseases such as depression
and Parkinson’s disease. In our study, we demonstrated that
EEB treatments increased the level of TH by 168.6 ± 21.0%, in
comparison to that in vehicle-treated animals. Therefore, our
results demonstrate that B. braunii may act as an antidepressant
by enhancing catecholamine synthesis in the brain.
Energy metabolic pathways [including
glycolysis/gluconeogenesis, the tricarboxylic acid (TCA) cycle,
and oxidative phosphorylation] have been studied extensively
in major depression disorder (Reininghaus et al., 2013). In our
study, we reported the variation in the expression of Pnpt1 and
Arrdc4 genes, which are involved in energy production. The
Pnpt1 gene product is a polynucleotide phosphorylase (PNPase),
an enzyme associated with the import of nucleus-encoded RNAs
such as transfer RNA (tRNA), 5S ribosomal RNA (5S rRNA),
ribonuclease P RNA (RNase P RNA), and MRP (mitochondrial
RNA processing) RNAse into mitochondria. These nucleus-
encoded RNAs are essential for mitochondrial DNA replication,
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FIGURE 3 | Effects of the administration of ethanol extract of B. braunii (EEB)
on the ATP levels in imprinting control region mouse cerebrum. Mice were
orally administered water (control), imipramine (20 mg/kg), and EEB (100
mg/kg) daily for 14 consecutive days. Values are expressed as the means ±
SEM (n = 4 independent experiments) and were analyzed by one-way ANOVA
followed by Ryan-einot-gabriel-welsch multiple range test, *P < 0.05 vs.
control group.
FIGURE 4 | Effect of ethanol extract of B. braunii (EEB) on the
corticosterone-induced changes in PC12 cell viability. Values are expressed as
the means ± SEM (n = 5 independent experiments) and were analyzed by
one-way ANOVA followed by Ryan-einot-gabriel-welsch multiple range test,
**P < 0.01 vs. control cells, ##P < 0.01 vs. corticosterone-treated cells.
transcription, and translation (Kamenski et al., 2007; Tarassov
et al., 2007; Duchene et al., 2009; Smirnov et al., 2011). It is
reported that deficiency of PNPase leads to cellular changes
secondary to mitochondrial dysfunction, which include lactate
accumulation, reduction in steady-state ATP levels, and reduced
cell proliferation (Chen et al., 2006). The expression of Arrdc4,
a negative regulator of glucose uptake (Patwari et al., 2009), was
also downregulated in the cerebrum of EEB-administered ICR
mice. Glucose is a fundamental nutrient, providing ATP for
energy as well as carbon for biosynthesis (Vander Heiden et al.,
2009). In addition, from the microarray results, we determined
the gene expression of pyruvate carboxylase (PC), the rate-
limiting enzyme catalyzing the ATP-dependent carboxylation
of pyruvate to oxaloacetate. Our findings demonstrate that EEB
may have an antidepressant-like effect by enhancing the level
of energy availability. Interestingly, we demonstrated that only
EEB treatments increased PC expression and ATP level in mouse
cerebrum, while treatment with imipramine was ineffective on
both of these parameters.
It is reported that ATP can induce an increase of BDNF
expression (Klein et al., 2012). In our study, we demonstrated
that EEB significantly increased BDNF gene expression in
mouse brain. BDNF is essential for neurogenesis and for the
rearrangement of axonal arbors in the brain (Jeanneteau et al.,
2010). Furthermore, it has been shown that the exogenous
application of BDNF to hippocampal neurons alleviates the
neurotoxic insult induced by corticosterone (Nitta et al.,
1999). In our in vitro experiment, we confirmed that 200µM
corticosterone induced a significant decrease in the viability of
PC12 cells. However, EEB attenuated the cell death induced
by corticosterone. This result indicates a close functional
relationship between BDNF and glucocorticoids, and may
explain the important role of BDNF in the modulation of
major depressive disorder. In addition to our findings, previous
publications demonstrated that the promotion of neurogenesis
in mouse hippocampus could be the mechanism underlying
the antidepressant-like effect of some drugs (Ito et al., 2008).
Moreover, it was shown that compounds with an antidepressant-
like effect in animalmodels of chronic unpredicted stress restored
the levels of BDNF expression in hippocampal neurons and
astrocytes (Jin et al., 2013).
Our results from the microarray analysis also revealed that
EEB treatment induced the overexpression of a few genes related
to the process of neurogenesis (Shox2, Pitx2, Tshz1, and Lhx9).
Shox2 plays an important role during cerebellar neurogenesis, by
maintaining the proper balance of morphogen sonic hedgehog
and bone morphogenetic protein (BMP) expression levels (Rosin
et al., 2015). The Pitx2 gene product is necessary for the normal
development of the subthalamic nucleus and its projections to
the tegmentum, as well as for the development of the projections
arising in the midbrain. Pitx2 protein is expressed in postmitotic
neurons of the midgestation central nervous system, including
GABAergic neurons of the future thalamus and midbrain,
and neurons of the subthalamic nucleus (Martin et al., 2002).
Moreover, Pitx2 is required to establish functional connectivity
of these terminally differentiated neurons (Martin et al., 2004).
Tshz1 is expressed in the developing olfactory bulb (OB) and
the dorsolateral ganglionic eminence (Caubit et al., 2005). It
is reported that the major function of Tshz1 in the OB is to
maintain the expression of prokineticin receptor 2, a G protein-
coupled receptor essential for OB development and related to
prokineticin signaling (Ragancokova et al., 2014). Prokineticin
signaling is involved in several biological processes, including
nociception, circadian rhythm, and neurogenesis (Ng et al., 2005;
Hu et al., 2006; Li et al., 2012). Lhx9 was isolated by degenerate
RT-PCR followed by mouse embryonic library screening. Lhx9
is one of the typical marker genes of neurogenesis at the
stage of immature neuronal cells (Peukert et al., 2011). These
results suggest that EEB treatment induced the enhancement of
neurogenesis through the promotion of energy production.
The results from our study showed that B. braunii has
an antidepressant-like effect in ICR mice with FST-induced
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depression. This microalga may contain proteins, carbohydrates,
lipids, or bioactive molecules such as n-3 PUFA and carotenoids
that exert an antidepressant-like effect. And, B. braunii
produces carotenoids including β-carotene, lutein, violaxanthin,
canthaxanthin, astaxanthin, and zeaxanthin (Ranga Rao et al.,
2006, 2010). A number of reports have been published on studies
in which attempts were made to elucidate the antidepressant
effect of these active substances. For example, astaxanthin was
shown to improve the impaired behavior in an animal model of
autism, presumably by its antioxidant activity (Al-Amin et al.,
2015). Additionally, n-3 PUFAs are under investigation for their
possible use in the treatment and prevention of depression.
An early study in rodents demonstrated that a reduction of
dietary n-3 PUFA intake induced a decrease in the levels of
nerve growth factor (NGF) in the hippocampus, and that NGF
levels in different brain regions were affected differently by
dietary n-3 PUFA deficiency and restoration (Ikemoto et al.,
2000). Interestingly, meta-analysis of clinical trials using a
combination of different types of n-3 PUFA, such as EPA and
DHA, supplementation in patients with affective disorders and
depression showed the therapeutic benefit of this combination
for the amelioration of symptoms in patients affected by major
depressive disorder (Grosso et al., 2014). Therefore, B. braunii,
which is rich in n-3 PUFA and carotenoids, may be useful as
a new therapeutic agent for depression. Further studies on the
chemical composition of B. braunii will be necessary.
CONCLUSION
In summary, we report here for the first time evidence showing
that B. braunii exerts an antidepressant-like effect in an
animal model of depression. This appears to be mediated by
the enhancement of energy promotion, neurogenesis, and
dopamine synthesis in the brain. The observed effects of this
alga showed in terms of significant differences compared
with imipramine, a commercial antidepressant drug that
was used as a positive control in this study, indicating a
difference in the molecular mechanism underlying their
antidepressant effects. These molecular mechanisms are
currently not understood and will be the focus of our future
research.
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